Li W, Xiong A, Yang N, Fan H, et al. Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study. J Clin Oncol 2024 Jun 1:JCO2400731. doi: 10.1200/JCO.24.00731.
PMID: 38822758